Sharemaestro Newsreel

Dimensional Fund Advisors LP Raises Stock Position in Ardagh Metal Packaging S.A. $AMBP

Dimensional Fund Advisors LP increased its stake in Ardagh Metal Packaging S.A. (NYSE:AMBP) by 20.9% in the first quarter, now owning 0.78% of the company. Other institutional investors also adjusted their positions, with hedge funds and institutions collectively holding 16.93% of the stock. Despite …

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Foghorn Therapeutics Inc. (NASDAQ:FHTX) has received a "Moderate Buy" consensus rating from eight analysts, with an average 12-month price target of $11.43, significantly higher than its $6.07 opening price. The company recently surpassed quarterly expectations, reporting a smaller loss per share and higher revenue …

Falcon's Beyond Global (NASDAQ:FBYD) Trading 2.4% Higher - Here's Why

Shares of Falcon's Beyond Global (NASDAQ:FBYD) rose 2.4% to $10.07 on Friday, despite trading volume being 28% below average. This increase follows an upgrade from "sell" to "hold" by Weiss Ratings, while the overall analyst consensus remains "Hold." Institutional investors hold a significant 38.88% …

Haemonetics (NYSE:HAE) Upgraded by Wall Street Zen to Strong-Buy Rating

Wall Street Zen has upgraded Haemonetics (NYSE:HAE) to a "strong-buy" rating, reflecting positive analyst sentiment and strong financial performance. The company exceeded quarterly expectations with $1.14 EPS and $339.38 million in revenue, leading management to raise its fiscal 2027 revenue-growth outlook to 5%-8%. Haemonetics' …

Power Solutions International, Inc. $PSIX Shares Purchased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its stake in Power Solutions International, Inc. (NASDAQ:PSIX) by 40.3% in the first quarter, now owning 1.23% of the company's stock. Other institutional investors like Vanguard Group Inc., Arrowstreet Capital, Situational Awareness LP, and ANTIPODES PARTNERS Ltd also expanded …

Dimensional Fund Advisors LP Has $16.48 Million Stock Position in Johnson Outdoors Inc. $JOUT

Dimensional Fund Advisors LP recently reduced its stake in Johnson Outdoors Inc. (NASDAQ:JOUT) by 7.4%, selling 28,289 shares, but still holds 354,397 shares valued at $16.48 million. Despite this, institutional ownership remains high at 64.05%, with several other funds increasing their positions. Analysts have …

Blackstone entities (NASDAQ: MDLN) report 153.3M Medline shares, 16.5% stake

Blackstone-affiliated entities and Stephen A. Schwarzman have filed an updated ownership report for Medline Inc. (MDLN), revealing a beneficial ownership of 153,327,675 shares of Class A common stock, which represents a 16.5% stake. This ownership includes Class A shares and Common Units exchangeable into …

Norwood Financial (NASDAQ:NWFL) Shares Pass Above 200 Day Moving Average - Should You Sell?

Norwood Financial (NASDAQ:NWFL) shares have risen above their 200-day moving average, trading at $33.83, surpassing the average of $30.59. Analysts maintain a "Moderate Buy" rating with a $35 average price target, despite the company's recent quarterly EPS of $0.86 slightly missing estimates. The company …

Aurora Investment Managers LLC. Lowers Position in Mid-America Apartment Communities, Inc. $MAA

Aurora Investment Managers LLC significantly reduced its stake in Mid-America Apartment Communities (MAA) by 78.3% in Q2, selling 16,253 shares and retaining 4,506 shares valued at $626,000. Despite this, institutional investors collectively own 93.6% of MAA's outstanding shares, with other major firms like Norges …

Abner Herrman & Brock LLC Has $28.15 Million Stake in The Boeing Company $BA

Abner Herrman & Brock LLC significantly increased its stake in The Boeing Company, now holding 130,043 shares valued at $28.15 million, making it their 12th largest portfolio position. Despite Boeing reporting a quarterly loss of $0.76 per share, analysts maintain a "Moderate Buy" rating …

Align Technology, Inc. $ALGN Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in Align Technology, Inc. (NASDAQ:ALGN) by 36.2% in the second quarter, selling over 358,000 shares. Despite this, other institutional investors like Capital International Investors and Invesco Ltd. increased their holdings. Align Technology reported strong Q2 earnings, …

Janus Henderson Group PLC Has $5.28 Million Holdings in Align Technology, Inc. $ALGN

Janus Henderson Group PLC reduced its stake in Align Technology, Inc. by 25.4% in the first quarter, now holding 30,791 shares valued at $5.28 million. Align Technology exceeded Q1 earnings expectations, reporting $2.64 EPS and $1.06 billion in revenue, and has a "Moderate Buy" …

DMC Global (NASDAQ:BOOM) Upgraded to Buy at Wall Street Zen

Wall Street Zen has upgraded DMC Global (NASDAQ:BOOM) from a "hold" to a "buy" rating, though the overall analyst consensus remains "Hold" with a $9.00 price target. The company recently reported strong quarterly earnings, exceeding expectations with $0.04 EPS and $156.95 million in revenue, …

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Recommendation of "Moderate Buy" by Brokerages

Merit Medical Systems, Inc. (NASDAQ:MMSI) has received a consensus "Moderate Buy" rating from brokerages, with eight out of eleven analysts recommending a buy and three suggesting a hold. The average 12-month price target is $100.30, exceeding its opening price of $89.04. The company recently …

Teleflex (TFX) Stock Slides On Margin Strain Despite Higher EPS Outlook

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has an average "Hold" recommendation from analysts, with nine firms rating it Hold, three Sell, and three Buy. The company's Q2 earnings beat expectations with an adjusted EPS of $0.52 and revenue of $898 million, though revenue declined year-over-year. Analysts …

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of "Buy" by Brokerages

Analysts have issued a "Buy" consensus rating for CytomX Therapeutics (NASDAQ:CTMX), with an average 12-month price target of $12.10, significantly higher than its current share price of $3.46. Despite this positive outlook, the company reported a wider-than-expected quarterly loss of $0.09 per share and …

AMN Healthcare Services Inc (NYSE:AMN) Receives Average Recommendation of "Hold" from Analysts

Analysts have given AMN Healthcare Services Inc (NYSE:AMN) an average "Hold" rating, with a 12-month price target below its current stock price. Despite a challenging staffing market, the company reported strong second-quarter results, significantly exceeding EPS and revenue expectations, driven by growth in travel …

Wall Street Zen Upgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to "Hold"

Wall Street Zen has upgraded Mirum Pharmaceuticals (NASDAQ:MIRM) from "sell" to "hold" despite broader analyst coverage maintaining a "Moderate Buy" rating with a $137.33 price target. This upgrade comes as Mirum Pharmaceuticals reported better-than-expected second-quarter revenues of $176.24 million, a 37.9% year-over-year increase, though …

NexGen Energy (NYSE:NXE) Upgraded to "Sell" at Wall Street Zen

Wall Street Zen has upgraded NexGen Energy (NYSE:NXE) from a "strong sell" to a "sell" rating, despite the overall analyst consensus remaining a "Hold." The article notes that NexGen shares opened at $10.41, up 1.8%, with a market capitalization of approximately $6.97 billion. Institutional …

The Bank of Nova Scotia (TSE:BNS) Given Average Recommendation of "Hold" by Brokerages

Ten research firms have given The Bank of Nova Scotia (TSE:BNS) an average "Hold" recommendation, with an average 12-month price target of C$112.31. The bank recently reported solid quarterly earnings of C$2.02 per share on C$9.85 billion in revenue and increased its quarterly dividend …

La-Z-Boy (NYSE:LZB) Rating Lowered to "Hold" at Wall Street Zen

Wall Street Zen has downgraded La-Z-Boy (NYSE:LZB) from a "buy" to a "hold" rating, though Weiss Ratings upgraded it to "buy," maintaining an overall "Moderate Buy" consensus among analysts with a $39.00 target price. The company recently reported strong quarterly earnings of $1.26 per …

Monolithic Power Systems (NASDAQ:MPWR) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen has upgraded Monolithic Power Systems (NASDAQ:MPWR) from a "hold" to a "buy" rating, contributing to a consensus "Moderate Buy" rating for the stock with an average price target of $1,705.82. This upgrade follows the company's strong quarterly performance, where it exceeded …

Dentsply Sirona (XRAY) Stock Drops As Revenue Weakens Despite Profit Rebound

Kestra Medical Technologies (NASDAQ:KMTS) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen Upgrades ICU Medical (NASDAQ:ICUI) to Strong-Buy

Wall Street Zen has upgraded ICU Medical (NASDAQ:ICUI) to a "strong-buy" rating, reflecting generally positive analyst sentiment and recent strong financial performance. The company exceeded quarterly expectations with EPS of $2.37 and revenue of $547.9 million, and it provided optimistic fiscal 2026 EPS guidance. …

INmune Bio (NASDAQ:INMB) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen has upgraded INmune Bio (NASDAQ:INMB) from a "Sell" to a "Hold" rating, though Weiss Ratings simultaneously downgraded it from "Sell (D-)" to "Sell (E+)." Despite this mixed sentiment, MarketBeat's overall analyst consensus for INmune Bio remains a "Moderate Buy." The company, …

Entegris (NASDAQ:ENTG) Downgraded by Wall Street Zen to Buy

Wall Street Zen downgraded Entegris (NASDAQ:ENTG) from a "strong buy" to a "buy" rating, though broader analyst consensus remains a "Moderate Buy" with an average price target of $165.56. Entegris reported strong quarterly results, beating EPS estimates with $0.93 and achieving an 11.5% year-over-year …

Miller Industries (NYSE:MLR) Upgraded to "Strong-Buy" at Wall Street Zen

Miller Industries (NYSE:MLR) was upgraded to a "strong-buy" rating by Wall Street Zen, moving from a "hold" rating. This upgrade comes after the company reported strong quarterly earnings, beating analyst estimates for both EPS and revenue. Despite the upgrade from Wall Street Zen, the …

Wall Street Zen Upgrades Caesarstone (NASDAQ:CSTE) to "Hold"

Wall Street Zen has upgraded Caesarstone (NASDAQ:CSTE) from a "strong sell" to a "hold" rating, though Weiss Ratings maintains a "sell (D-)", resulting in an overall "Sell" consensus among analysts. Caesarstone opened at $2.30, with a market capitalization of $79.5 million, and reported a …

KE Holdings Inc. Sponsored ADR (NYSE:BEKE) Given Consensus Rating of "Moderate Buy" by Analysts

KE Holdings Inc. Sponsored ADR (NYSE:BEKE) has received a "Moderate Buy" consensus rating from seven analysts, with an average 12-month price target of $23.07, suggesting potential upside from its current share price of $17.06. Analyst sentiment has generally improved, with some firms upgrading the …

Wall Street Zen Downgrades Borr Drilling (NYSE:BORR) to Strong Sell

Wall Street Zen has downgraded Borr Drilling (NYSE:BORR) from a "sell" to a "strong sell" rating, despite other analysts maintaining a "Moderate Buy" consensus with an average target price of $4.88. This downgrade follows Borr Drilling reporting a quarterly loss of $0.09 per share …

Pulse Biosciences (NASDAQ:PLSE) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded Pulse Biosciences (NASDAQ:PLSE) from "hold" to "sell," despite a broader analyst consensus of "Moderate Buy" with an average price target of $32.33. The company's stock opened at $42.41, up 10.9%, but it missed analyst expectations for its last quarterly …

Solventum Corporation (NYSE:SOLV) Receives Consensus Rating of "Hold" from Brokerages

Solventum Corporation (NYSE:SOLV) has received a consensus "Hold" rating from thirteen brokerages, with an average 12-month price target of $91.64, surpassing its opening price of $83.00. The company's Q2 results exceeded expectations, reporting adjusted EPS of $2.55 against a $1.91 consensus and revenue of …

Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors

Two AtriCure directors, including Maggie Yuen, sold shares after a strong second quarter where the company reported 13% revenue growth and raised its full-year outlook. Yuen sold 3,500 shares, reducing her direct equity stake by 20%, though the timing of sales by multiple directors …

Kaplan Fox Encourages Investors of Medline Inc. (MDLN) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (MDLN) following a warning letter from the FDA regarding "significant violations of Current Good Manufacturing Practice regulations" and inadequate cleaning practices. The FDA letter, dated May 28, 2026, led to a …